Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of 18F-FLT Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Cases of Prefibrotic/Early Primary Myelofibrosis (PMF) and Essential Thrombocythemia (ET)

NCT03116542 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT03116542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03116542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of 18F-FLT Positron Emission Tomography/Computed Tomography (PET/CT) Imaging in Cases of Prefibrotic/Early Primary Myelofibrosis (PMF) and Essential Thrombocythemia (ET)
Lead sponsor
Hamad Medical Corporation
Phase
Not applicable
Overall status
Unknown status
Start date
May 7, 2017
Completion date
August 31, 2021
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

essential thrombocythemia, primary myelofibrosis, fibrotic stage, primary myelofibrosis, prefibrotic stage